chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No additional adverse events reported; administration of expired dose of MMR II; This spontaneous report was received from a pharmacist, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided.  On 21-FEB-2022, the patient was vaccinated with expired dose (expired product administered) of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) 0.5 milliliter, lot #: T001212, expiration date: 12-JAN-2022, albumin status: recombinant human albumin (rHA) (site and route of administration were not provided) for prophylaxis. There was no additional adverse event reported.
Information has been received from a Medical Assistant (M.A.) concerning a 27 year old female patient who was vaccinated on 04-APR-2007 in to deltoid with a third dose of Gardasil lot #656049/0187U one week earlier than the recommended schedule. Concomitant therapy included prenatal vitamins (manufacturer unknown). After the third injection, the injection site area was "swollen, red and warm to touch". The size of the area was a 6 inch circumference. The patient sought unspecified medical attention. Her outcome was unknown at time of this report. Additional information has been requested.
I thought I was having heart attack.; At midnight I woke up with severe chest pains.; Nausea; It was severe gas & cramping.; It was severe gas & cramping.; This is a spontaneous report from a non-contactable consumer (patient). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 15Mar2021 19:30 (Batch/Lot Number: 1621146-00) (at the age of 68 years old) as 1st dose, single for COVID-19 immunization. The patient had no other medical history and concomitant medications were not reported. The patient previously took polyethylene glycol and had known allergies to the medication. No other vaccine in four weeks. The shot given was at 19:30. At midnight (16Mar2021 12:00 AM), the patient woke up with severe chest pains. She thought she was having heart attack. It was severe gas (Gas in chest) and cramping. The patient had this almost daily for 2 weeks. She had nausea for one week. The patient reported that she never experienced this in her life and still happens at least once a week. There has been no change in her diet before or after the vaccination. Events usually will be relieved within 2 hours after taking GasX. No COVID prior vaccination and patient had not been tested for COVID post vaccination. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies or concomitant medications were not provided. In November 2017, also reported as "the date between 08-NOV-2017 to 14-NOV-2017", the patient received one separate dose of improperly stored PNEUMOVAX 23 Lot # N010105, expiry date on 15-NOV-2018, for prophylaxis (strength and route were not reported). The vaccine was stored at a temperature at or above 32°F (Farenheit) to 35°F during 15 minutes. No previous temperature excursions were reported and the call was because of a data logger. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1711USA006632.
severe diarrhea with shot 1 and high fever (104.2) with shot 2, no sense of taste/smell with shot 2
Pneumonia; scan showed infiltration in the lungs; coughing; absolute eosinophils were high 22.2 and came down to 4.8 now; This is a spontaneous report from a non-contactable consumer (wife). An 81-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04Jan2021 at SINGLE DOSE for COVID-19 immunisation.  Medical history included Running nose from 01Jan2021.  The patient's concomitant medications were not reported.  The patient received Covid vaccine on the 04Jan2021. She stated on 01Jan2021 he had running nose, had negative covid test so was given the Covid vaccine. She said 7 days after the first dose on 11Jan2021, he had pneumonia, was in the hospital, scan showed infiltration in the lungs, coughing. He was on the antibiotics and prednisone. The absolute eosinophils were high 22.2 and came down to 4.8 now. She wanted to know if that was an allergic reaction to the vaccine.   No follow up attempts are possible. Information about Lot and batch number could not be obtained.
pt found unresponsive in crib 10AM; CPR @ home, intubated by EMT, could not be resuscitated;
Information has been received from a registered nurse concerning a 23 year old patient of unknown gender. The patient's pertinent medical history, drug reactions, allergies, concurrent conditions and concomitant therapies were not informed. On 18-NOV-2016, the patient was vaccinated with the first dose of VARIVAX,  lot # M031969, expiration date 30-JUN-2018, 0.5 ml administered per subcutaneous route for prophylaxis. On 12-DEC-2016, the patient received the second dose of VARIVAX, lot # M031969, expiration date 30-JUN-2018, 0.5 ml administered per subcutaneous route for prophylaxis. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
I got Covid seven weeks after the fourth booster.  I had 100.1 degree fever for about three days, cough, and fatigue. I had a virtual appointment with a PA.  She suggested Robitussin DM, Tylenol if needed, rest and lots of fluids.
Acute Hypertension and Chest pressure/Pain.  BP went from 120/80 to 177/118
Information has been received from a registered nurse concerning an 8 year old male who on 07/10/95 was vaccinated with Varivax. On 03/01/02, the patient presented to the doctor's office with otitis media (right ear) and a rash all overt that was consistent with chicken pox, per physician. The patient was treated with amoxicillin trihydrate (Amoxil) (400 mg) for otitis media. The patient sought unspecified medical attention. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of dizziness 1 hour after shot in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 027A21A) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 5, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Mar 5, 2021, patient experienced dizziness 1 hour after shot. At the time of the report, dizziness 1 hour after shot outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information provided.
Pt received PNEUMOVAX 7/28 then began fever to 102. On 07/30/15 developed urticaria requiring ER visit with prednisone, ZOFRAN, ranitidine and diphenhydramine given. No known allergy ingestion.
Client vaccinated with 2 doses of Pfizer vaccine for Covid in March and April, 2021.  Symptoms started 11/23/2021 - runny nose, cough, myalgia, sore throat.  Tested PCR + on 12/1/2021.
Severe Premature Ventricular Contraction (PVCs) four days after second vaccine.  Resolved with IV administration of magnesium.  Recurred and continued at a lesser frequency for the following week.  Magnesium  taken daily (orally 400mg).  Some shortness of breath and lightheadesness.  EKG normal on 6/02/21.  Echo scheduled on 7/14/21.
Day after shot the site was red and hard about the size of a quarter.  After a week, the  site is now bruised and itchy/tender.
He began experiencing "pins and needles in his feet and legs."; Sore arm; Fatigue; This is a spontaneous report from a contactable consumer (patient himself). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) via an unspecified route of administration on 07Aug2021 (Batch/Lot number was not provided) as single dose for COVID-19 immunization. Medical history included COVID-19 infection from Feb2021 (6 Months ago). The patient's concomitant medications were not reported. The patient stated he received his first dose of the Pfizer BioNTech Covid-19 Vaccine on Saturday 07Aug2021. Patient stated he did not have anything immediate or serious occur after vaccination, "just a sore arm and some fatigue the next day (08Aug2021) and also stated that by day four post vaccination on 10Aug2021 and he began experiencing pins and needles in his feet and legs. The patient stated "it seems like it's getting a little bit better and spoke with his primary care physician and they did not provide much insight for him. The patient stated he had Covid-19 infection six months ago and he has heard that some people who have had Covid-19 infection and later were vaccinated seemed to have worse side effects after their first dose. The patient asking if these side effects he experienced are considered severe and how long they may last and also if, given his side effects after the first dose, he should still receive the second dose of the Pfizer BioNTech Covid-19 Vaccine. The outcome of the events was recovering.   Information regarding Lot/Batch number not available.
Delayed menstrual cycle previous cycle length: 29-33 days  dose 1 given on day 29, cycle was 36 days. subsequent cycles 33-36 days with increased PMS symptoms including headache at ovulation and cycle day 1
pt recvd vax & lab eval revealed that pt was pos for hep B core antibody, neg for surface antigen & neg for surface antibody; No further details were provided;
This case was reported by a nurse and described the occurrence of stiff neck in a 45-year-old female subject who was vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis. There were no concurrent medications. The subject had no pre-existing medical conditions. On 05 October 2005 the subject received 1st dose of Engerix-B in the right arm (lot 131AA-incomplete lot number). At an unspecified time following the administration of the 1st dose of Engerix-B, on an unspecified date in October 2005, the subject experienced a stiff neck. The stiff neck resolved on an unspecified date before the 2nd dose of Engerix-B. On an unspecified date in November 2005, before 17 November 2005, the subject received the 2nd dose of Engerix-B. At an unspecified time following the 2nd dose of Engerix-B, on an unspecified date in November 2005, the subject again experienced a stiff neck. The subject was hospitalized. The stiff neck resolved "about two to three days following the 2nd dose" of Engerix-B, on an unspecified date on or before 17 November 2005. The nurse considered the stiff neck to possibly be related to vaccination with Engerix-B.
VOICE SOUNDS LIKE A FROG; STUFFED UP IN NOSE AREA; BODY ACHES FROM HEAD TO TOE; CHILLS; HEADACHE; SORENESS IN ARM; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204B21A, and expiry: UNKNOWN) dose was not reported, administered on 23-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On 23-AUG-2021, the patient experienced soreness in arm. On 24-AUG-2021, the patient experienced voice sounds like a frog. On 24-AUG-2021, the patient experienced stuffed up in nose area. On 24-AUG-2021, the patient experienced body aches from head to toe. On 24-AUG-2021, the patient experienced chills. On 24-AUG-2021, the patient experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from soreness in arm, was recovering from chills, and had not recovered from body aches from head to toe, stuffed up in nose area, voice sounds like a frog, and headache. This report was non-serious.
Case number PHHY2012US051945 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unspecified date after vaccination she was diagnosed with arrhythmia. The outcome of pregnancy was not reported. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA.
Pt had small bruise at site of injection for several days. Arm started aching that evening (injection given between 3-6PM at immunization walk-in clinic) Aching became progressively worse over next wk. (Had no swelling, redness or fever) Had trouble sleeping, more pain when lying down; improving but still aching; hard to lift arm without pain, takes Advil
Fever, light headedness, diarrhea, lethargy, slightly impaired cognitions.
Mom gave APAP to pt p/vax given; Pt woke up screaming had 1 episode vomiting; Pt cried intermittently 1.5 hr then fell asleep; "felt warm to touch"; no temp taken; On 730AM of 13FEB91 t98.7 ax;
Patient hospitalized for acute ETOH withdrawal.  Covid result incidental.  Unable to obtain vaccine administration dates or place.
I experienced muscle soreness at the injection site (upper-left arm) around 9P followed by cramping of my left calf. I went to bed and work up at 2A with body aches, stiffness, and joint throughout my body. The next day I continued experiencing the cramp in my leg and body aches, stiffness, and joint pain throughout my body, and general fatigue. The symptoms were mostly gone after my second night's sleep. I am still feeling lingering (mild) soreness and fatigue today, 4/2/2021.
Previously dx'd with Autism in 10/99 and had no behavior or sensory problems X 1 year. Declassified in 8/01. Four days, post vax, reoccurrence of severe autistic behaviors including self-injury, screaming perseveration, animal-like behaviors, unsafe actions, altered sensory difficulties, increased attention deficit and hyperactivity. A rash was seen on abdomen the 2nd and 4th weeks after vaccine. Follow up reports states "Reoccurrence of Autistic Behaviors, including self-injurious behaviors- ? tics, infantile behaviors, excessive non-verbal gestures,increase in impulsive and unsafe behaviors, attention deficit,hyperactivity, urinary incontinence, mood swings."
Mom 1st called to office with concerns of diarrhea after vaccine administered x 3-4 t days, green stools, so different from usual BM's, did vomit day of admin. Came to office 2/19/07, no signs acute abd. Reassured mom and discussed signs of distress.
got the flu too; Initial information received on 21-Dec-2022 regarding an unsolicited valid social media non-serious case received from a consumer/non-healthcare professional (hcp).  This case involves an unknown age and unknown gender patient who got the flu too after receiving vaccine INFLUENZA VACCINE  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, route, dose: unknown) (lot number and expiry date: not reported) in unknown administration site for prophylactic vaccination (Immunisation).  On an unknown date, the patient got his/her and got the flu too (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events. It is unknown if the patient had any medical history, concomitant disease or risk factor. It is unknown if there were lab data/results available.   Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (got the flu too).  At time of reporting, the outcome was Unknown.
There was no adverse reaction at time of reporting. Pfizer Bivalent was given in error. Monovalent should have been administered.
sore arm; red itchy circle; This is a spontaneous report from a contactable Consumer (self-report). This 71-year-old female consumer patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown, Expiry date: Unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. She received her first dose of the Pfizer covid vaccine 1 1/2 weeks ago (will be 2 weeks on 15Feb2021). She developed a sore arm for a day and a half after the injection but developed a round red itchy circle under the arm on the arm where she didnt receive the injection at all. States it has become smaller in size. She has a doctors appoiment this coming Monday. She found an image on a website of a local reaction to the vaccine that was identical to what she has (doesnt remember the website). Adds that her daughters husbands friend also developed a little lump after receiving the Pfizer covid vaccine. asking for information on this side effect of the vaccine.  Information on the lot/ batch number has been requested.
Tdap was given intra-articular, instead of intramuscular, resulting in acute capsulitis/bursitis.  Onset of symptoms was 4 hours after injection.
about 2 weeks after this vaccine she received a second influenza vaccine from an urgent care clinic as well. 3 weeks ago she started having an itchy rash on her face and upper chest, sparing the eyes, mouth. there was an erythematous, bumpy appearance. treated with 7 days of prednisone 40mg per day with resolution but returning within 48h off of prednisone.
Pt requested COVID Booster dose and influenza vaccine but 2 doses of COVID vaccine administered.  Pt transferred to Urgent Care for further evaluation but left without intervention.  Pt advised of return precautions.
Severe headache 12 hours after vaccine. Rash left arm starting 4 days after injection that is not going away and possible getting worse.
recently had a "titer test" and physician recommended that she have the MMR II administered as her " "titers were low"/ lack of efficacy; she have the MMR II administered as her " "titers were low"; This spontaneous report refers to a 55-year-old female patient reporting on herself. The patient's historical condition included allergic reaction to a unspecified tentnus vaccine. The patient's current condition included allergy to neomycin. There was no information about the patient's concomitant therapies. On an unknown date (reported as on a unspecified date in the late fifties or early sixties), the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) in the unspecified arm (dose, route of administration, lot # and expiration date were not reported) for prophylaxis. On an unknown date, the patient had a titer test and the physician recommended that the patient had the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) administered as her titers were low. The patient did not receive any treatment for the events. Due to response and lack of efficacy the adverse event was filed as a precaution. The patient didn't sought medical attention.  The outcome of the events and the causality assessment between the events and suspect therapy was not provided.
itching on the shoulder blade after first shot; Fatigue after first shot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on the shoulder blade after first shot) and FATIGUE (Fatigue after first shot) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PRURITUS (itching on the shoulder blade after first shot) and FATIGUE (Fatigue after first shot). On 27-Mar-2021, FATIGUE (Fatigue after first shot) had resolved. On 05-Apr-2021, PRURITUS (itching on the shoulder blade after first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
After the shot got extremely light headed and ended up falling down a flight of stairs which ended in a broken bone that will need surgery to fix. Surgery was May, 27th and had to go in for a second surgery on June 28th.
This spontaneous report as received from a sales representative of another company refers to a group of unspecified nurses of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with RECOMBIVAX HB (dose, frequency, route and site of administration, lot # and expiry date were not reported) for prophylaxis. On an unknown date, the nurses attended a wellness event at their unspecified employer and were told that they would need boosters of RECOMBIVAX HB as a result of their antibody levels were not at therapeutic range. The outcome of the event was unknown. The relatedness between the event and the suspect therapy was not provided. Additional information has been requested.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/25/2023 Discharge Date: Mar 3, 2023  PRESENTING PROBLEM: Hypoxia  COVID-19    HOSPITAL COURSE: 84 year old female presented with complaints of sore throat, headache and fatigue and also exertional hypoxia. She was found to have covid infection and was hypoxemic requiring nasal cannula.  CXR shows pulmonary congestion. She was started on remdesevir and decadron. Her LFTs remained normal the entire duration of her stay.Her hypoxia improved from requiring 3 liters down to 1 liter. Transition to Home consulted, patient enrolled and pulmo rehab for follow up and home med respectively .    During her hospital stay she was found to have  anemia. Indices indicative of microcytic hypochromic Iron and iron sat , Zinc all were low  and were repleted.    On day of discharge she was noted to be in atrial flutter in varying conductance She is known to heart facility, started on NOAC ( after questionable history of CVA perhaps bleed was ruled out ) , and cardizem. Her heart rate controlled, with Highest heart rate up to  98 on ambulation . Echo showed no pericardial effusion , mild pulmonary HTN ( also known and following with Pulmonary service, her EF 50% )    Discharged on 3/3/2023 hemodynamically  stable, tolerating meals and ambulation .  Zio patch on discharge
Initial misuse report received from a healthcare professional on 26 February 2013. A patient (no other information was provided regarding the patient) had just received a 0.4% sodium chloride diluent of ACT-HIB vaccine on an unspecified date. No adverse event was reported. List of documents held by sender: none.
Severe vomiting x 2 days, foster mother was advised to push fluids including PEDIALYTE and if dehydration occurred to go to ER, fussiness was also noted.